Citation: M. Boyd et al., EFFECT OF A(1) ADENOSINE RECEPTOR AGONIST AND ANTAGONIST ON [H-3] GLUTAMIC-ACID RELEASE FROM CORTICAL TISSUE IN-VITRO, The FASEB journal, 10(3), 1996, pp. 920-920
Citation: Y. Meshulam et al., PROPHYLACTIC TRANSDERMAL TREATMENT WITH PHYSOSTIGMINE AND SCOPOLAMINEAGAINST SOMAN INTOXICATION IN GUINEA-PIGS, Journal of applied toxicology, 15(4), 1995, pp. 263-266
Authors:
JACOBSON KA
SIDDIQI SM
OLAH ME
JI XD
MELMAN N
BELLAMKONDA K
MESHULAM Y
STILES GL
KIM HO
Citation: Ka. Jacobson et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF 9-ALKYLADENINE AND RIBOSE-MODIFIED ADENOSINE DERIVATIVES AT RAT A(3) ADENOSINE RECEPTORS, Journal of medicinal chemistry, 38(10), 1995, pp. 1720-1735
Authors:
VONLUBITZ DKJE
KIM J
BEENHAKKER M
CARTER MF
LIN RCS
MESHULAM Y
DALY JW
SHI D
ZHOU LM
JACOBSON KA
Citation: Dkje. Vonlubitz et al., CHRONIC NMDA RECEPTOR STIMULATION - THERAPEUTIC IMPLICATIONS OF ITS EFFECT ON ADENOSINE A(1) RECEPTORS, European journal of pharmacology, 283(1-3), 1995, pp. 185-192
Authors:
VONLUBITZ DKJE
CARTER MF
DEUTSCH SI
LIN RCS
MASTROPAOLO J
MESHULAM Y
JACOBSON KA
Citation: Dkje. Vonlubitz et al., THE EFFECTS OF ADENOSINE A(3) RECEPTOR STIMULATION ON SEIZURES IN MICE, European journal of pharmacology, 275(1), 1995, pp. 23-29
Authors:
LEVY A
BRANDEIS R
TREVES TA
MESHULAM Y
MAWASSI F
FEILER D
WENGIER A
GLIKFELD P
GRUNWALD J
DACHIR S
RABEY JM
LEVY D
KORCZYN AD
Citation: A. Levy et al., TRANSDERMAL PHYSOSTIGMINE IN THE TREATMENT OF ALZHEIMERS-DISEASE, Alzheimer disease and associated disorders, 8(1), 1994, pp. 15-21